G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 124 filers reported holding G1 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $71,052 | -80.6% | 26,512 | -60.8% | 0.00% | -100.0% |
| Q4 2022 | $367,068 | -95.8% | 67,600 | -83.1% | 0.00% | -97.4% |
| Q2 2021 | $8,773,000 | +143.2% | 399,844 | +166.7% | 0.04% | +129.4% |
| Q1 2021 | $3,607,000 | +2674.6% | 149,936 | +1982.4% | 0.02% | +1600.0% |
| Q4 2020 | $130,000 | -94.9% | 7,200 | -93.1% | 0.00% | -93.8% |
| Q2 2020 | $2,527,000 | -51.9% | 104,157 | -13.8% | 0.02% | -23.8% |
| Q2 2018 | $5,253,000 | -36.7% | 120,865 | -46.0% | 0.02% | -40.0% |
| Q1 2018 | $8,299,000 | +109.1% | 224,000 | +12.0% | 0.04% | +105.9% |
| Q4 2017 | $3,968,000 | – | 200,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |